NASDAQ Rheumatology Market News
Anthera Pharmaceuticals Announces Completion of Dosing in CHABLIS-SC1 Phase 3 Clinical Study with Blisibimod
HAYWARD, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announced that ...
Apricus Biosciences to Present at the Canaccord Genuity 36th Annual Growth Conference
SAN DIEGO, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
U.S. News and World Report Names University of Colorado Hospital to Best Hospitals Honor Roll
AURORA, Colo., Aug. 2, 2016 (GLOBE NEWSWIRE) -- For the first time, U.S. News ...
pSivida Corp and Hospital for Special Surgery Innovation Center Announce Opening of IND for Sustained-Release Implant for Severe Knee Osteoarthritis
WATERTOWN, Mass. and NEW YORK, Aug. 01, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) ...
pSivida Corp and Hospital for Special Surgery Innovation Center Announce Opening of IND for Sustained-Release Implant for Severe Knee Osteoarthritis
WATERTOWN, Mass. and NEW YORK, Aug. 01, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) ...
Apricus Biosciences Announces Corporate Update and Second Quarter 2016 Financial Results Conference Call
SAN DIEGO, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
Apricus Biosciences Announces Corporate Update and Second Quarter 2016 Financial Results Conference Call
SAN DIEGO, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
Apricus Biosciences Announces Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Lebanon
SAN DIEGO, July 27, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
Apricus Biosciences Further Expands Existing Vitaros® Partnership with Ferring Pharmaceuticals in Europe and Asia
Apricus Eligible to Receive an Additional $3.6 Million in Upfront and Pre-Commercialization Milestone Payments ...
Horizon Pharma plc to Host Second-Quarter 2016 Conference Call and Webcast on August 8, 2016
DUBLIN, Ireland, July 07, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical ...
Apricus Biosciences Enters Into Common Stock Purchase Agreement With Aspire Capital
SAN DIEGO, July 06, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI) (the “Company” ...
Rheumatology Leaders Respond to MACRA Proposed Rule
WASHINGTON, June 24, 2016 (GLOBE NEWSWIRE) -- In comments submitted to the Centers for ...
Rheumatology Providers, FDA Leaders Discuss Biosimilar Policy Challenges and Opportunities at National Policy Briefing
WASHINGTON, June 20, 2016 (GLOBE NEWSWIRE) -- Experts from the American College of Rheumatology ...